Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
  1. 4 Grant or award Chief Legal Officer acquired 109,956 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Director sold 7,750 shares at $28.54 ($221,185)
  4. 4 Planned sale Director sold 5,425 shares at $28.54 ($154,830)
  5. 4 Open-market sale Chief Legal Officer sold 3,650 shares at $25.45 ($92,893)
  6. 4 Open-market sale Chief Medical Officer sold 3,353 shares at $25.45 ($85,334)
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 6 of 18 · 360 filings